Literature DB >> 19143477

Survival of mice immunized with monoclonal antibodies against glycoprotein E of Japanese encephalitis virus before or after infection with Japanese encephalitis, West Nile, and Dengue viruses.

A K Gupta1, V J Lad, A A Koshy.   

Abstract

In the present study, the effect of monoclonal antibodies (MAbs) against glycoprotein E (gE) of Japanese encephalitis virus (JEV) strain 733913 administered 1 day before or 2 days after intracerebral (i.c.) challenge with West Nile virus (WNV) strain 68856 or Dengue virus (DENV-2) strain P23085, was studied in mice. Furthermore, two JEV strains belonging to group II (strains 641686 and 691004) that have lost reactivity against virus-specific MAbs were also used in passive immunization experiments. MAbs as ascitic fluids were administered intraperitoneally (i.p.) in mice. Hemagglutination-inhibition- (HAI) positive JEV-specific (Hs-3) MAbs given 2 days after the virus infection showed reduced mortality along with increased survival of mice challenged with WNV or with DENV-2. Also the HAI-positive flavivirus cross-reactive (Hx) MAbs produced a marginal increase in the survival of mice challenged with both JEV strains 641686 and 691004 belonging to the group II. As the MAbs reacting with HAI-positive JEV-specific (Hs) and HAI-negative JEV-specific (NHs) epitopes were neutralizing and protective in mice against JEV strain 733913 challenge, the results indicated presence of the cross-protection phenomenon that might be occurring in some of the localities endemic for the three closely related flaviviruses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19143477

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  2 in total

1.  Pathogenesis of Japanese encephalitis virus infection in a golden hamster model and evaluation of flavivirus cross-protective immunity.

Authors:  Angela Bosco-Lauth; Gary Mason; Richard Bowen
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

2.  Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice.

Authors:  Albert To; Liana O Medina; Kenji O Mfuh; Michael M Lieberman; Teri Ann S Wong; Madhuri Namekar; Eileen Nakano; Chih-Yun Lai; Mukesh Kumar; Vivek R Nerurkar; Axel T Lehrer
Journal:  mSphere       Date:  2018-01-10       Impact factor: 4.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.